Concepts (63)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cell Death | 3 | 2013 | 262 | 0.520 |
Why?
|
| Apoptosis | 2 | 2010 | 1717 | 0.440 |
Why?
|
| Panax | 2 | 2013 | 170 | 0.390 |
Why?
|
| Genes, Retinoblastoma | 1 | 2010 | 22 | 0.360 |
Why?
|
| Ginsenosides | 1 | 2010 | 123 | 0.350 |
Why?
|
| Gene Silencing | 1 | 2010 | 178 | 0.340 |
Why?
|
| Neoplasms, Experimental | 1 | 2010 | 269 | 0.320 |
Why?
|
| Plant Extracts | 2 | 2013 | 245 | 0.310 |
Why?
|
| Antioxidants | 1 | 2009 | 226 | 0.310 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2010 | 414 | 0.300 |
Why?
|
| Cell Cycle Proteins | 1 | 2010 | 401 | 0.290 |
Why?
|
| Drosophila Proteins | 1 | 2010 | 508 | 0.250 |
Why?
|
| Mutation | 2 | 2010 | 4137 | 0.200 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2010 | 89 | 0.170 |
Why?
|
| Reactive Oxygen Species | 3 | 2013 | 490 | 0.170 |
Why?
|
| Colorectal Neoplasms | 3 | 2013 | 981 | 0.160 |
Why?
|
| Blotting, Western | 2 | 2010 | 794 | 0.160 |
Why?
|
| NF-kappa B | 2 | 2013 | 466 | 0.160 |
Why?
|
| Polymorphism, Genetic | 2 | 2010 | 824 | 0.130 |
Why?
|
| Vacuoles | 2 | 2013 | 46 | 0.120 |
Why?
|
| HCT116 Cells | 2 | 2013 | 155 | 0.120 |
Why?
|
| Cell Line, Tumor | 2 | 2010 | 2553 | 0.120 |
Why?
|
| Sapogenins | 1 | 2013 | 24 | 0.110 |
Why?
|
| Anticarcinogenic Agents | 1 | 2013 | 73 | 0.100 |
Why?
|
| Breast Neoplasms | 3 | 2010 | 3003 | 0.100 |
Why?
|
| Phytotherapy | 1 | 2013 | 136 | 0.100 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 2010 | 25 | 0.090 |
Why?
|
| Caspase Inhibitors | 1 | 2010 | 33 | 0.090 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2010 | 53 | 0.090 |
Why?
|
| Free Radical Scavengers | 1 | 2010 | 59 | 0.090 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2010 | 67 | 0.090 |
Why?
|
| Caspases | 1 | 2010 | 155 | 0.090 |
Why?
|
| Acetylcysteine | 1 | 2010 | 70 | 0.090 |
Why?
|
| Trinucleotide Repeats | 1 | 2010 | 32 | 0.090 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2010 | 198 | 0.090 |
Why?
|
| Receptors, Androgen | 1 | 2010 | 122 | 0.080 |
Why?
|
| HEK293 Cells | 1 | 2010 | 638 | 0.080 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2009 | 315 | 0.080 |
Why?
|
| Cell Survival | 1 | 2010 | 982 | 0.080 |
Why?
|
| Oxidative Stress | 1 | 2010 | 458 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2010 | 2338 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2010 | 1940 | 0.070 |
Why?
|
| Drosophila | 1 | 2010 | 521 | 0.070 |
Why?
|
| Signal Transduction | 2 | 2013 | 3376 | 0.060 |
Why?
|
| Models, Biological | 1 | 2009 | 1764 | 0.050 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2010 | 2399 | 0.050 |
Why?
|
| Humans | 7 | 2013 | 89157 | 0.050 |
Why?
|
| Odds Ratio | 2 | 2010 | 684 | 0.040 |
Why?
|
| Mice | 1 | 2010 | 11743 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2010 | 1855 | 0.030 |
Why?
|
| Risk Factors | 3 | 2010 | 5483 | 0.030 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2013 | 31 | 0.030 |
Why?
|
| Chemoprevention | 1 | 2013 | 92 | 0.030 |
Why?
|
| Risk Assessment | 2 | 2010 | 2302 | 0.030 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2013 | 277 | 0.020 |
Why?
|
| Pyridines | 1 | 2013 | 315 | 0.020 |
Why?
|
| Animals | 1 | 2010 | 27330 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 360 | 0.020 |
Why?
|
| Mitochondria | 1 | 2013 | 553 | 0.020 |
Why?
|
| Exons | 1 | 2010 | 451 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2010 | 685 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2010 | 944 | 0.020 |
Why?
|
| Female | 3 | 2010 | 46078 | 0.010 |
Why?
|